Evidence map›Paper›PMID 36830243›Full record

ReviewAntibiotics (Basel, Switzerland)2023

Evolution of

Lyudmila Boyanova, Petyo Hadzhiyski, Raina Gergova, Rumyana Markovska

Abstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Levofloxacin and Rifampin Resistance inAntibiotics (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Eco-Friendly Synthesis and Characterization ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  9. Novel anti-virulence strategy againstFrontiers in microbiology · 2026
    Article
  10. Old drugs, new weapons: current trends in repurposing therapies against antimicrobial resistance.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Sequential changes of antibiotic resistances ofWorld journal of gastroenterology · 2025
    Article
  17. High Prevalence ofAntibiotics (Basel, Switzerland) · 2025
    Article
  18. Article
  19. Review
  20. Towards EffectiveInternational journal of molecular sciences · 2025
    Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lyudmila BoyanovaDepartment of Medical Microbiology, Medical Faculty, Medical University of Sofia, Zdrave str. 2, 1431 Sofia, Bulgaria.ORCID 0000-0001-9622-0873
Petyo HadzhiyskiSpecialized Hospital for Active Pediatric Treatment, Medical University of Sofia, "Acad. Ivan Evstatiev Geshov" blvd., 1606 Sofia, Bulgaria.
Raina GergovaDepartment of Medical Microbiology, Medical Faculty, Medical University of Sofia, Zdrave str. 2, 1431 Sofia, Bulgaria.
Rumyana MarkovskaDepartment of Medical Microbiology, Medical Faculty, Medical University of Sofia, Zdrave str. 2, 1431 Sofia, Bulgaria.ORCID 0000-0003-1634-8768

Funding

Medical University of Sofia D-129/14.06.2022
6 · The paper itself

Abstract

Antibiotic resistance among

Indexed as

amoxicillinantibioticclarithromycinevolutionHelicobacter pyloriincreaselevofloxacinmetronidazoleresistancetetracycline

Identifiers

PMID36830243
PMCPMC9952372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.